【EPED Inc.】Q1 2026 EPS 1.39 yuan

Key facts

  • 【EPED Inc.】Q1 2026 EPS 1.39 yuan
  • EPED Inc. in the biotech and medical sector announced its Q1 2026 financial results, achieving high profitability with an EPS of 1.39 yuan, revenue of 219 million yuan, and net profit after tax of 48 million yuan.
  • Source: PR Times
  • Date: March 1, 2026

Direct answer

EPED Inc. in the biotech and medical sector announced its Q1 2026 financial results, achieving high profitability with an EPS of 1.39 yuan, revenue of 219 million yuan, and net profit after tax of 48 million yuan.

Citation
【EPED Inc.】Q1 2026 EPS 1.39 yuan (March 1, 2026), PR Times
Source
PR Times
Date
March 1, 2026
EPED Inc. in the biotech and medical sector announced its Q1 2026 financial results, achieving high profitability with an EPS of 1.39 yuan, revenue of 219 million yuan, and net profit after tax of 48 million yuan.
その他NQ 0/100出典：PR Times

📋 Article Processing Timeline

  • 📰 Published: March 1, 2026 at 09:00
  • 🔍 Collected: May 15, 2026 at 08:01 (1799h 1m after Published)
  • 🤖 AI Analyzed: May 15, 2026 at 21:46 (13h 45m after Collected)
Company Code: 6918
Company Name: EPED Inc.
Industry: Biotechnology and Medical Care
Year/Quarter: 2026 Q1
Basic Earnings Per Share: 1.39 yuan
Operating Revenue: 219 million yuan
Net Profit After Tax: 0.48 billion yuan

FAQ

What are the key facts in this article?

EPED Inc. in the biotech and medical sector announced its Q1 2026 financial results, achieving high profitability with an EPS of 1.39 yuan, revenue of 219 million yuan, and net profit after tax of 48 million yuan.

What is the direct answer?

EPED Inc. in the biotech and medical sector announced its Q1 2026 financial results, achieving high profitability with an EPS of 1.39 yuan, revenue of 219 million yuan, and net profit after tax of 48 million yuan.

What is the source and date?

PR Times: https://openapi.twse.com.tw/financial/twse-fin-6918-2026Q1 | March 1, 2026

Back to Newsroom (13)